Defensible, multi-method valuation reports that stand up to investor scrutiny.
We triangulate value using multiple methodologies. Each method provides a different lens. Combined, they give investors a defensible range.
Projects future free cash flows and discounts them to present value using a risk-adjusted WACC. Best for companies with predictable revenue and positive unit economics.
Benchmarks your company against publicly traded peers using revenue, EBITDA, or user-based multiples. Provides a market-validated range that investors understand immediately.
Analyses recent M&A and funding rounds in your sector. Shows what acquirers and investors have actually paid for companies similar to yours.
Values the company based on net asset value - tangible and intangible. Most relevant for asset-heavy businesses like mining, property, and manufacturing.
Works backwards from a target exit value, applying expected returns at each funding stage. The standard approach for early-stage VC-backed companies.
Adjusts a base valuation using qualitative factors: team strength, market size, product stage, competitive position, and capital efficiency. Useful for pre-revenue companies.
From focused single-method assessments to comprehensive multi-method reports.
Up to 6 methods: DCF, comparable companies, precedent transactions, Berkus, venture capital method, and scorecard. We typically present 2-3 in a range.
Usually not as the primary method. We use Berkus, scorecard, or VC method for pre-revenue companies and include DCF as a secondary reference only.
Very. We anchor every assumption to market data, comparable transactions, or verified metrics. Investors respect the methodology.
Always a range. A single number invites argument. A well-supported range with clear methodology invites negotiation from a position of strength.